Cochrane Abstracts
Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tamoxifen or Letrozole Versus Standard Methods for Women With Estrogen-receptor Positive Breast Cancer Undergoing Oocyte or Embryo Cryopreservation in Assisted Reproduction: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen_receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction:_Cochrane_systematic_review. Accessed 14 October 2024.
Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen_receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction:_Cochrane_systematic_review. Accessed October 14, 2024.
Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen_receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction:_Cochrane_systematic_review
Tamoxifen or Letrozole Versus Standard Methods for Women With Estrogen-receptor Positive Breast Cancer Undergoing Oocyte or Embryo Cryopreservation in Assisted Reproduction: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 October 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen_receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction: Cochrane systematic review
ID - 435089
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435089/all/Tamoxifen_or_letrozole_versus_standard_methods_for_women_with_estrogen_receptor_positive_breast_cancer_undergoing_oocyte_or_embryo_cryopreservation_in_assisted_reproduction:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
